Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Phase II trial to study the effectiveness of flavopiridol in treating
patients who have relapsed or refractory multiple myeloma